Merit Medical Systems (Nasdaq: MMSI ) is expected to report Q4 earnings on Feb. 21. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Merit Medical Systems's revenues will grow 10.8% and EPS will grow 26.7%.
The average estimate for revenue is $100.9 million. On the bottom line, the average EPS estimate is $0.19.
Last quarter, Merit Medical Systems logged revenue of $95.9 million. GAAP reported sales were 6.0% higher than the prior-year quarter's $90.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.20. GAAP EPS of $0.17 for Q3 were 55% higher than the prior-year quarter's $0.11 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 47.3%, 190 basis points better than the prior-year quarter. Operating margin was 9.8%, 120 basis points worse than the prior-year quarter. Net margin was 7.5%, 250 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $392.8 million. The average EPS estimate is $0.76.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 85 members out of 90 rating the stock outperform, and five members rating it underperform. Among 24 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 23 give Merit Medical Systems a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Merit Medical Systems is outperform, with an average price target of $15.67.
Is Merit Medical Systems the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.